Exclusive: NIH has paused patenting of discoveries

For the past five weeks, employees at NIH technology transfer offices have been barred from filing new patent applications.

March 7, 2025 Check out STAT+

Sponsored By

Adobe STAT+ | NIH has paused patenting of discoveries, slowing their use in developing treatments Employees at NIH technology transfer offices have been barred from filing new patent applications, and sharing of research materials halted By Megan Molteni STAT+ | UnitedHealth continues making stealthy deals, pushing deeper into medical care as scrutiny mounts Financial documents show the sprawling conglomerate acquired or created 250 subsidiaries in 2024 as it continues an ambitious vertical integration strategy. By Bob Herman STAT+ | Health care providers form a united front against stricter patient privacy rules Health care providers are pushing back against stricter federal patient privacy rules proposed in response to rising cybersecurity threats. By Katie Palmer Gretchen Ertl/Whitehead Institute STAT+ | Q&A: How 'blast zone' of gender politics is hurting research on women's health In a Q&A, David Page of the Whitehead Institute says politics is putting women's health researchers in "double jeopardy." By Elizabeth Cooney Opinion: The long history of the U.S. trying to control and dismantle the WHO The United States has often used its political muscle and the power of the purse to threaten and coerce the World Health Organization. By Theodore M. Brown STAT+ | NIH abruptly terminates millions in research grants, defying court orders The sweeping actions would appear to violate court rulings from federal judges that block freezing or ending such government spending By Kay Lazar and Liz Kowalczyk — Boston Globe Adobe STAT+ | Opinion: Volatile is the new normal for the biotech workforce While working at biotech startups has always involved risk, the biotech industry has recently evolved into an especially volatile dynamic. By Gairik Sachdeva

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser